We can’t show the full text here under this license. Use the link below to read it at the source.
1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview
Recent overview of 1,2,3-triazole-based compounds as promising drug candidates
AI simplified
Abstract
1,2,3-triazole-containing hybrids and conjugates have been identified as lead compounds for various biological targets.
- These compounds may exhibit properties such as anticancer, antimicrobial, and antiviral activities.
- 1,2,3-triazoles can be synthesized using 'click' chemistry methods, which involve copper- or ruthenium-catalysed reactions.
- Recent advancements in this area have led to the creation of a novel class of compounds.
- The review covers developments in medicinal chemistry related to these triazole-containing compounds published in 2018.
- Findings may assist researchers in organic synthesis, medicinal chemistry, phytochemistry, and pharmacology.
AI simplified